BioPharma Pharma Research
Calypso Biotech Announces First Patient with Eosinophilic Esophagitis Dosed in Anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1a/b Trial, and Animal Proof of Concept Data in Atopic Dermatitis
Healthy volunteers phase completed showing differentiating target engagement biomarker data and favorable safety data On track for top-line histology da...
December 19, 2022 | News
FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer
"This approval provides healthcare professionals with an innovative treatment option for patients with high-risk non-muscle invasive bladder cancer that is...
December 19, 2022 | News
BioVaxys Announces Results from The Ohio State University Pan-Sarbecovirus Animal Study
The Company previously demonstrated that BVX-0320 stimulated a strong antibody and T cell response in a murine model, and believes that administering BVX-1...
December 19, 2022 | News
Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases
Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations ...
December 15, 2022 | News
Over £175 million for cutting-edge genomics research to help boost diagnosis treatment for patients
£105 million to speed up diagnosis of rare genetic diseases in newborns, potentially resulting in life-saving interventions for thousands of babies...
December 15, 2022 | News
Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19
Based on Ascletis' Phase I results of ASC10 and molnupiravir's clinical efficacy data in American, Japanese and Chinese patients, 800 mg twice daily of ASC...
December 13, 2022 | News
Fraunhofer IZI Selects Lonza’s MOD A-ES® Solution to Digitalize Manufacturing Operations
The Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) has chosen Lonza’s MODA-ES® Manufacturing Execution System (M...
December 06, 2022 | News
Griffith joins $280 million partnership to deliver mRNA vaccine outcomes
The $280 million Translational Science Hub will be established under an agreement between Sanofi, Griffith University, the University of Queensland and the...
December 05, 2022 | News
How Optoacoustic Imaging Plays a Role in Assessing the Success of Breast Cancer Surgery
This first-in-human study was carried out by a team of researchers and clinicians at A*STAR’s Institute of Bioengineering and Bioimaging (IBB)&...
December 05, 2022 | News
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that ...
December 02, 2022 | News
MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022
At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99* Genetic Sequencer at Booth C209. Suitable for small and med...
December 02, 2022 | News
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual ...
December 01, 2022 | News
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development
AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide...
November 25, 2022 | News
Australian Scientists Honoured with the Grand Hamdan Award
The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd of ...
November 25, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
